MyD88 provides a protective role in long-term radiation-induced lung injury.

Published

Journal Article

The role of innate immune regulators is investigated in injury sustained from irradiation as in the clinic for cancer treatment or from a nuclear incident. The protective benefits of flagellin signaling through Toll-like receptors (TLR) in an irradiation setting warrant study of a key intracellular adaptor of TLR signaling, namely Myeloid differentiation primary response factor 88 (MyD88). The role of MyD88 in regulating innate immunity and Nuclear factor kappa-B (NF-κB)-activated responses targets this critical factor for influencing injury and recovery as well as maintaining immune homeostasis.To examine the role of MyD88, we examined immune cells and factors during acute pneumonitic and fibrotic phases in Myd88-deficient animals receiving thoracic gamma (γ)-irradiation.We found that MyD88 supports survival from radiation-induced injury through the regulation of inflammatory factors that aid in recovery from irradiation. The absence of MyD88 resulted in unresolved pulmonary infiltrate and enhanced collagen deposition plus elevated type 2 helper T cell (Th2) cytokines in long-term survivors of irradiation.These results based only on a gene deletion model suggest that alterations of MyD88-dependent inflammatory processes impact chronic lung injury. Therefore, MyD88 may contribute to attenuating long-term radiation-induced lung injury and protecting against fibrosis.

Full Text

Duke Authors

Cited Authors

  • Brickey, WJ; Neuringer, IP; Walton, W; Hua, X; Wang, EY; Jha, S; Sempowski, GD; Yang, X; Kirby, SL; Tilley, SL; Ting, JP-Y

Published Date

  • April 2012

Published In

Volume / Issue

  • 88 / 4

Start / End Page

  • 335 - 347

PubMed ID

  • 22248128

Pubmed Central ID

  • 22248128

Electronic International Standard Serial Number (EISSN)

  • 1362-3095

International Standard Serial Number (ISSN)

  • 0955-3002

Digital Object Identifier (DOI)

  • 10.3109/09553002.2012.652723

Language

  • eng